Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes

Open access

Abstract

Dyskeratosis congenita (DC) is a multisystem bone marrow failure syndrome characterized by a triad of mucocutaneous abnormalities and a predisposition to cancer. The genetic basis of DC remains unknown in more than 60% of patients. Mutations have been identified in components of the telomerase complex (dyskerin, TERC, TERT, NOP10, and NHP2), and recently in one component of the shelterin complex TIN2 (gene TINF2). To establish the role of TINF2 mutations, we screened DNA from 175 uncharacterised patients with DC as well as 244 patients with other bone marrow failure disorders. Heterozygous coding mutations were found in 33 of 175 previously uncharacterized DC index patients and 3 of 244 other patients. A total of 21 of the mutations affected amino acid 282, changing arginine to histidine (n = 14) or cysteine (n = 7). A total of 32 of 33 patients with DC with TINF2 mutations have severe disease, with most developing aplastic anaemia by the age of 10 years. Telomere lengths in patients with TINF2 mutations were the shortest compared with other DC subtypes, but TERC levels were normal. In this large series, TINF2 mutations account for approximately 11% of all DC, but they do not play a significant role in patients with related disorders. This study emphasises the role of defective telomere maintenance on human disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2008-05-153445

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Conservation of amino acids in a small region of TIN2 between different species. Close-up of the residues mutated in the patients with DC. Arrows indicate the sites of mutations. Changes are K280X (n = 2), R282C (n = 7), R282H (n = 14), P283A, P283H, P283S, T284A, T284Hfs8X, L287P, P289S, F290LfsX2, R291G, and Q298RfsX19. Red indicates highly conserved; blue, limited conservation; black, no conservation. Alignment obtained using MultAlin.20
Figure 1 Conservation of amino acids in a small region of TIN2 between different species. Close-up of the residues mutated in the patients with DC. Arrows indicate the sites of mutations. Changes are K280X (n = 2), R282C (n = 7), R282H (n = 14), P283A, P283H, P283S, T284A, T284Hfs8X, L287P, P289S, F290LfsX2, R291G, and Q298RfsX19. Red indicates highly conserved; blue, limited conservation; black, no conservation. Alignment obtained using MultAlin.20CC BY-NC · PubMed Central
Figure 2 Telomere lengths in patients with DC with TINF2 mutations are the shortest compared with other DC subtypes. (A) Telomere lengths in healthy controls (○, n = 112), patients (♦, n = 16) and parents (, n = 15). (B) Telomere length compassion between DC patients with TINF2 mutations (♦, n = 16), DKC1 mutations (, n = 67) and healthy controls (○, n = 112). The line of best fit for the healthy controls is shown in panels A and B. (C) Comparison of age-adjusted delta Tel in healthy controls and patients with DKC1 and TINF2 mutations. The box represents the interquartile range which contains the 50% of values. The whiskers are lines that extend from the box to the highest and lowest values, excluding outliers and extreme outliers (○ and , respectively). A line across the box indicates the median.
Figure 2 Telomere lengths in patients with DC with TINF2 mutations are the shortest compared with other DC subtypes. (A) Telomere lengths in healthy controls (○, n = 112), patients (♦, n = 16) and parents (, n = 15). (B) Telomere length compassion between DC patients with TINF2 mutations (♦, n = 16), DKC1 mutations (, n = 67) and healthy controls (○, n = 112). The line of best fit for the healthy controls is shown in panels A and B. (C) Comparison of age-adjusted delta Tel in healthy controls and patients with DKC1 and TINF2 mutations. The box represents the interquartile range which contains the 50% of values. The whiskers are lines that extend from the box to the highest and lowest values, excluding outliers and extreme outliers (○ and , respectively). A line across the box indicates the median.CC BY-NC · PubMed Central
Figure 3 TERC/ABL levels are not reduced in patients with DC with TINF2 mutations. Comparison of TERC/ABL levels between healthy controls (n = 24), patients with DC with TINF2 mutations (n = 5), and patients with DC with DKC1 mutations (n = 26). The P value between TERC/ABL levels for TINF2 and DKC1 patients is given. The box represents the interquartile range which contains the 50% of values. The whiskers are lines that extend from the box to the highest and lowest values, excluding outliers (△). A line across the box indicates the median.
Figure 3 TERC/ABL levels are not reduced in patients with DC with TINF2 mutations. Comparison of TERC/ABL levels between healthy controls (n = 24), patients with DC with TINF2 mutations (n = 5), and patients with DC with DKC1 mutations (n = 26). The P value between TERC/ABL levels for TINF2 and DKC1 patients is given. The box represents the interquartile range which contains the 50% of values. The whiskers are lines that extend from the box to the highest and lowest values, excluding outliers (△). A line across the box indicates the median.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 317

Metadata

Authors
Walne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I.
Affiliations
Queen Mary University of London (GB)
Corresponding author
  • Walne, Amanda J.
  • Vulliamy, Tom
Venue
Blood
Published
2008-11-01
Volume
112
Issue
9
Pages
3594-3600
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2170632126
Cited by
317
References
26
Citations by year
2026: 9 · 2025: 12 · 2024: 13 · 2023: 9 · 2022: 12 · 2021: 18 · 2020: 16 · 2019: 14 · 2018: 16 · 2017: 13 · 2016: 19 · 2015: 15 · 2014: 27 · 2013: 26 · 2012: 13
FWCI
19.24
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Blood (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Queen Mary University of London
  • Wellcome Trust
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Hematology › Blood disorders and treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
TIN2, dyskeratosis congenita, bone marrow failure syndromes, telomere length, telomere maintenance, shelterin complex, TERC, telomerase reverse transcriptase, dyskerin, NOP10, NHP2, aplastic anemia, genetic mutations, disease severity
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Amino Acid Sequence, Base Sequence, Bone Marrow Diseases, Child, Child, Preschool, Female, Heterozygote, Humans, Infant, Infant, Newborn, Male, Middle Aged, Molecular Sequence Data, Mutation, RNA, Syndrome, Cohort Studies, Telomere, Sequence Homology, Amino Acid, DNA Primers, Telomerase, Dyskeratosis Congenita, Amino Acid Substitution, Telomere-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. https://app.cochat.ai/papers/10.1182/blood-2008-05-153445
The paper
Walne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I. (2008). TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood. https://doi.org/10.1182/blood-2008-05-153445

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.